Rotpunkt Apotheke Bronchialpastillen neo
Rotpunkt Apotheke Bronchialpastillen neo is a medicine authorised by Swissmedic under authorisation number 69489. The authorisation holder is Tentan AG. The medicinal product code is Synthetic medicines and the dispensing category is E: Supplied in any retail outlet without specialist advice, for example glucose tablets or certain care products. First authorisation was granted on 11 September 2023 and the authorisation is valid without a time limit. ATC code R05FB02 places the medicine in the group Cough and cold preparations.
| Authorisation number | 69489 |
|---|---|
| Name | Rotpunkt Apotheke Bronchialpastillen neo |
| Full name | Rotpunkt Apotheke Bronchialpastillen neo, Lutschpastillen |
| Authorisation holder | Tentan AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | E · General sale |
| ATC code | R05FB02 |
| First authorisation | 11 September 2023 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Rotpunkt Apotheke Bronchialpastillen neo, Lutschpastillen | E | 11 September 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 36 | Tablette(n) | R05FB02 | 03.02.0. | E |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Rotpunkt Apotheke Bronchialpastillen neo authorised in Switzerland?
Yes. Rotpunkt Apotheke Bronchialpastillen neo is authorised by Swissmedic under authorisation number 69489, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Rotpunkt Apotheke Bronchialpastillen neo have?
Rotpunkt Apotheke Bronchialpastillen neo is in dispensing category E. Supplied in any retail outlet without specialist advice, for example glucose tablets or certain care products.
Who is the authorisation holder of Rotpunkt Apotheke Bronchialpastillen neo?
The authorisation holder is Tentan AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.